Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
23
|
pubmed:dateCreated |
1998-11-30
|
pubmed:abstractText |
The octadecaneuropeptide ODN (QATVGDVNTDRPGLLDLK), originally characterized as an endogenous ligand for central-type benzodiazepine receptors, increases intracellular calcium concentration ([Ca2+]i) in rat astroglial cells. A series of ODN analogues was synthesized, and each compound was studied for its ability to induce Ca2+ mobilization in cultured rat astrocytes. Replacement of each amino acid by an L-alanine residue (AlaScan) showed that the N-terminal region of the molecule was relatively tolerant to alanine substitution (2-8, 10), except for the Ala9-substituted analogue (9) which was totally devoid of activity. Pyroglutamization (21) and acetylation (22) of the Gln1 residue reduced the Ca2+ response suggesting that a free N-terminal amine function is required for full activity of ODN. Alanine substitution of the residues in the C-terminal region of the molecule (11-14, 16-18) significantly reduced the biological activity of ODN. In particular, modifications of the Leu15 residue (15, 20) abolished the Ca2+-mobilizing activity. The analogues [Ala9]ODN (9), [Ala15]ODN (15), [D-Thr9]ODN (19), and [D-Leu15]ODN (20) partially antagonized the Ca2+ response evoked by ODN. Most importantly, the octapeptide ODN11-18 (OP, 24) produced a dose-response curve that was superimposable to that obtained with ODN, indicating that the C-terminal region of the molecule possesses full biological activity. Finally, the AlaScan of OP revealed that replacement of the Leu5 residue by Ala (29) or D-Leu (33) totally suppressed the calcium response, confirming the crucial contribution of the Leu15 residue of ODN to the biological activity of the neuropeptide.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Diazepam Binding Inhibitor,
http://linkedlifedata.com/resource/pubmed/chemical/GABA-A Receptor Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/GABA-A Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/diazepam binding inhibitor (33-50)
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4433-8
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9804683-Animals,
pubmed-meshheading:9804683-Astrocytes,
pubmed-meshheading:9804683-Calcium,
pubmed-meshheading:9804683-Cells, Cultured,
pubmed-meshheading:9804683-Diazepam Binding Inhibitor,
pubmed-meshheading:9804683-GABA-A Receptor Agonists,
pubmed-meshheading:9804683-GABA-A Receptor Antagonists,
pubmed-meshheading:9804683-Ligands,
pubmed-meshheading:9804683-Neuropeptides,
pubmed-meshheading:9804683-Oligopeptides,
pubmed-meshheading:9804683-Peptide Fragments,
pubmed-meshheading:9804683-Rats,
pubmed-meshheading:9804683-Rats, Wistar,
pubmed-meshheading:9804683-Structure-Activity Relationship
|
pubmed:year |
1998
|
pubmed:articleTitle |
Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes.
|
pubmed:affiliation |
European Institute for Peptide Research (IFRMP n degrees 23), Laboratory of Cellular and Molecular Neuroendocrinology, INSERM U413, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|